Retatrutide has emerged as a new medication in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By activating https://diegozcag235303.tribunablog.com/retatrutide-a-promising-new-treatment-for-obesity-50508805